» Articles » PMID: 19220486

Genetic Variation in Brain-derived Neurotrophic Factor and Human Fear Conditioning

Overview
Date 2009 Feb 18
PMID 19220486
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Brain-derived neurotrophic factor (BDNF) has been implicated in hippocampal-dependent learning processes, and carriers of the Met allele of the Val66Met BDNF genotype are characterized by reduced hippocampal structure and function. Recent nonhuman animal work suggests that BDNF is also crucial for amygdala-dependent associative learning. The present study sought to examine fear conditioning as a function of the BDNF polymorphism. Fifty-seven participants were genotyped for the BDNF polymorphism and took part in a differential-conditioning paradigm. Participants were shocked following a particular conditioned stimulus (CS+) and were also presented with stimuli that ranged in perceptual similarity to the CS+ (20, 40 or 60% smaller or larger than the CS+). The eye blink component of the startle response was measured to quantify fear conditioning; post-task shock likelihood ratings for each stimulus were also obtained. All participants reported that shock likelihood varied with perceptual similarity to the CS+ and showed potentiated startle in response to CS +/- 20% stimuli. However, only the Val/Val group had potentiated startle responses to the CS+. Met allele carrying individuals were characterized by deficient fear conditioning--evidenced by an attenuated startle response to CS+ stimuli. Variation in the BDNF genotype appears related to abnormal fear conditioning, consistent with nonhuman animal work on the importance of BDNF in amygdala-dependent associative learning. The relation between genetic variation in BDNF and amygdala-dependent associative learning deficits is discussed in terms of potential mechanisms of risk for psychopathology.

Citing Articles

Intolerance of uncertainty and threat generalization: A replication and extension.

Bauer E, MacNamara A, Sandre A, Lonsdorf T, Weinberg A, Morriss J Psychophysiology. 2020; 57(5):e13546.

PMID: 32057120 PMC: 7160017. DOI: 10.1111/psyp.13546.


Effects of BDNF Val66Met polymorphisms on brain structures and behaviors in adolescents with conduct disorder.

Jiang Y, Ming Q, Gao Y, Dong D, Sun X, Zhang X Eur Child Adolesc Psychiatry. 2019; 29(4):479-488.

PMID: 31264106 DOI: 10.1007/s00787-019-01363-z.


Acute exercise-induced enhancement of fear inhibition is moderated by BDNF Val66Met polymorphism.

Keyan D, Bryant R Transl Psychiatry. 2019; 9(1):131.

PMID: 30967530 PMC: 6456490. DOI: 10.1038/s41398-019-0464-z.


Serotonin 5-HTTLPR Genotype Modulates Reactive Visual Scanning of Social and Non-social Affective Stimuli in Young Children.

Christou A, Wallis Y, Bair H, Zeegers M, McCleery J Front Behav Neurosci. 2017; 11:118.

PMID: 28690502 PMC: 5482294. DOI: 10.3389/fnbeh.2017.00118.


HPA Axis Interactions with Behavioral Systems.

Packard A, Egan A, Ulrich-Lai Y Compr Physiol. 2016; 6(4):1897-1934.

PMID: 27783863 PMC: 7219962. DOI: 10.1002/cphy.c150042.


References
1.
Vansteenwegen D, Crombez G, Baeyens F, Eelen P . Extinction in fear conditioning: effects on startle modulation and evaluative self-reports. Psychophysiology. 1998; 35(6):729-36. View

2.
Lissek S, Biggs A, Rabin S, Cornwell B, Alvarez R, Pine D . Generalization of conditioned fear-potentiated startle in humans: experimental validation and clinical relevance. Behav Res Ther. 2008; 46(5):678-87. PMC: 2435484. DOI: 10.1016/j.brat.2008.02.005. View

3.
LaBar K, Gatenby J, Gore J, LeDoux J, Phelps E . Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron. 1998; 20(5):937-45. DOI: 10.1016/s0896-6273(00)80475-4. View

4.
Monfils M, Cowansage K, LeDoux J . Brain-derived neurotrophic factor: linking fear learning to memory consolidation. Mol Pharmacol. 2007; 72(2):235-7. DOI: 10.1124/mol.107.038232. View

5.
Ou L, Gean P . Regulation of amygdala-dependent learning by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol-3-kinase. Neuropsychopharmacology. 2005; 31(2):287-96. DOI: 10.1038/sj.npp.1300830. View